{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-002070","form_type":"8-K","ticker":"AVR","cik":"0002011514","company_name":"Anteris Technologies Global Corp.","filed_at":"2026-01-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.984973+00:00","generated_at":"2026-05-16T09:01:35.814061+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Medtronic makes $90M strategic investment in Anteris; combined $320M capital raise","bullets":["Medtronic invested $90M in Anteris via stock purchase; Anteris also completed an underwritten common stock offering for total gross proceeds of $320M.","Proceeds to fund global pivotal PARADIGM trial and global commercialization of DurAVR THV (transcatheter heart valve).","PARADIGM trial is a randomized controlled trial of ~1000 patients comparing DurAVR THV to commercially available TAVRs; enrollment started Q4 2025.","Medtronic and Anteris may expand collaboration into other strategic areas; Medtronic joins Anteris' stockholder community."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-002070","json":"https://secwatch.observer/filing/0001140361-26-002070.json","markdown":"https://secwatch.observer/filing/0001140361-26-002070.md","text":"https://secwatch.observer/filing/0001140361-26-002070.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2011514/000114036126002070/0001140361-26-002070-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2011514/000114036126002070/ny20062007x8_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T09:01:35.814061+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}